Nonalcoholic fatty liver disease (NAFLD) is closely correlated with insulin resistance and
several metabolic syndrome features, but whether it could increase the risk of cardiovascular …

Abstract Background and Aim Non‐alcoholic fatty liver disease (NAFLD) is linked to
metabolic syndrome, and is known to be associated with impaired fasting glycemia and …

Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with diabetes
mellitus and increasing evidence suggests that patients with type 2 diabetes are at a …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. In
some patients with NAFLD, isolated steatosis can progress to advanced stages with non …

Objective As a subgroup of nonalcoholic fatty liver disease (NAFLD), patients with non‐
obese NAFLD may also have an increased risk of adverse hepatic and metabolic outcomes …

There have been several reports about the clinical association between type 2 diabetes
mellitus (DM) and nonalcoholic fatty liver disease (NAFLD). However, most of the studies …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities
associated with overweight and metabolic syndrome (MetS). Importantly, NAFLD is one of its …

Background & Aims The shift to redefine nonalcoholic fatty liver disease (NAFLD) as
metabolic associated fatty liver disease (MAFLD) can profoundly affect patient care, health …

OBJECTIVES: The significance of nonalcoholic fatty liver disease (NAFLD) among patients
with diabetes is unknown. We sought to determine whether a diagnosis of NAFLD …

Background Nonalcoholic fatty liver disease (NAFLD) is a growing health issue around the
world. Aim This study is to investigate whether adult prevalence of NAFLD correlates with …